Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON26283
NL-OMON26283
Completed
Not Applicable

Pre- and neonatal screening of hemoglobinopathies: a prospective study.

o0 sites2,000 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHemoglobinopathies

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hemoglobinopathies
Sponsor
o
Enrollment
2000
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

P.C. Giordano et al. A confidential inquiry estimating the number of patients affected with sickle cell disease and thalassemia major confirms the need for a preventive strategy in the Netherlands. hemoglobin (2004),28: 287-296

Disorders of hemoglobin. Genetics, pathophysiology and clinical managment. Edit by Steinberg et al. Cambridge Univ. Press 2001

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
o

Eligibility Criteria

Inclusion Criteria

  • •1\. Pregnant females before the 16th week of pregancy and newborns.
  • •2\. Informed consent.

Exclusion Criteria

  • •Known hemoglobinopathy.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Increasing Documentation and Disclosure of Sickle Cell Trait Status: An Implementation Science ApproachSickle Cell Trait
NCT05387564Nemours Children's Clinic114
Completed
Not Applicable
Screening for Renal Complications in Children and Young Adults With Major Sickle Cell DiseaseAnemiaSickle Cell Disease
NCT05211037Centre Hospitalier Universitaire de Nice18
Completed
Not Applicable
Collect of Cord Blood From Subjects at Risk for Sickle Cell Disease, for the Purpose of Laboratory ResearchSickle Cell Disease
NCT03876821Institut National de la Santé Et de la Recherche Médicale, France44
Completed
Not Applicable
Survey in a Population of Sickle Cell Disease Patients to Evaluate the Transition Between the Queen Fabiola Children Hospital and the CHU Brugmann Hospital, and the Quality of the Hospital Care Within the CHU Brugmann Hospital.Sickle Cell Disease
NCT02608580Brugmann University Hospital30
Completed
Not Applicable
HEMAGO Monitoring and Impact on the Occurrence of Complications During Pregnancy in Sickle Cell PatientsSickle Cell Disease and Pregnancy
NCT06620887Hospices Civils de Lyon100